Lightstone Ventures

www.lightstonevc.com

VCMatch tracks Lightstone Ventures as an investor focused on Biotech, Medtech, and Pharma companies, Pre-Seed and Seed rounds, and United States, Ireland, and Singapore markets. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage

Focus Areas

Biotech, Medtech, Pharma

Geography

United States, Ireland, and Singapore

Investment Thesis

Lightstone Ventures invests at the intersection of high-quality people and rigorous science — backing “visionary founders to translate novel scientific breakthroughs into clinically and commercially meaningful therapies.” They take a thesis-driven, hands-on approach: providing patient, long-term capital to fund companies “through its life cycle from start-up to commercialization,” and partnering closely with founders on strategy, operations and team-building rather than only writing checks.

Is Lightstone Ventures right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Lightstone Ventures is most relevant for founders raising Pre-Seed, Seed, and Series A rounds in Biotech, Medtech, Pharma, and Digital Health, especially across United States, Ireland, and Singapore.

Focus statement

LSV focuses on biotech and medtech — investing in first-in-class drugs across modalities (small molecules, biologics, cell & gene) with disease focus areas including CNS, immunology (particularly autoimmune), next-generation oncology and ophthalmology; and medtech companies at the convergence of technology, medicine and consumer health that leverage data analytics and scientific platforms to create personalized and targeted therapeutics.

Value Add

Team depth and operational track record — "nearly 100 years of company-building experience" with partners and advisors who have founded, operated, and led exits of many life‑science companies.
Hands-on, operator-led support — actively partnering with founders on day-to-day functions, strategy, team-building and commercialization rather than passive investing.
Thesis-driven, patient capital — explicit commitment to fund companies across their full lifecycle from startup to commercialization.
Global footprint — offices in the U.S. and Ireland to access non-U.S. strategic and financial partners and alternative development/commercialization strategies.
Strong incubator and industry ties — close relationship with The Foundry medical device incubator and a demonstrated string of exits and IPOs in both biotech and medtech.